(Q46123058)

19 December 2017

title

A novel serine phosphorylation site detected in the N-terminal domain of estrogen receptor isolated from human breast cancer cells (English)

1 reference

19 December 2017

1 reference

5

1 reference

19 December 2017

author name string

David J Britton

1

1 reference

19 December 2017

Gary K Scott

2

1 reference

19 December 2017

Birgit Schilling

3

1 reference

19 December 2017

Christian Atsriku

4

1 reference

19 December 2017

Bradford W Gibson

6

1 reference

19 December 2017

Christopher C Benz

7

1 reference

19 December 2017

Michael A Baldwin

8

1 reference

19 December 2017

publication date

4 March 2008

1 reference

19 December 2017

Journal of the American Society for Mass Spectrometry

published in

1 reference

19 December 2017

volume

19

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

729-740

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1016/j.jasms.2008.02.008

exact match

0 references

cites work

Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Selective oestrogen receptor modulation: molecular pharmacology for the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Estrogen receptor phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Analysis of protein phosphorylation on a proteome-scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Analysis of protein phosphorylation by hypothesis-driven multiple-stage mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Electrophoresis combined with novel mass spectrometry techniques: powerful tools for the analysis of proteins and proteomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Phosphoproteomic analysis of the developing mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Large-scale characterization of HeLa cell nuclear phosphoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Probability-based protein identification by searching sequence databases using mass spectrometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Targeting antihormone resistance in breast cancer: a simple solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Estrogen receptor and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Identification by mass spectrometry and functional characterization of two phosphorylation sites of KCNQ2/KCNQ3 channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JASMS.2008.02.008

Emerging applications for phospho-proteomics in cancer molecular therapeutics

21 January 2018

1 reference

12 December 2020

The estrogen receptor: a model for molecular medicine.

1 reference

12 December 2020

Phosphopeptide analysis by on-line immobilized metal-ion affinity chromatography-capillary electrophoresis-electrospray ionization mass spectrometry

1 reference

12 December 2020

Identification of phosphorylation sites using microimmobilized metal affinity chromatography.

1 reference

12 December 2020

Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor

1 reference

12 December 2020

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

1 reference

12 December 2020

Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.

1 reference

12 December 2020

10.1016/J.JASMS.2008.02.008

Identifiers

DOI

1 reference

19 December 2017

Dimensions Publication ID

1036151691

0 references

1 reference

19 December 2017